Thermo Fisher finalises FEI purchase
Thermo Fisher Scientific has completed its acquisition of FEI, with a total purchase price of approximately $4.2 billion.
All regulatory approvals have now been received and the business will become part of Thermo Fisher’s Analytical Instruments Segment.
As Marc N Casper, president and chief executive officer of Thermo Fisher Scientific, highlights: "With FEI’s leading electron microscopy platform, we’re now in an even stronger position to help our life sciences customers accelerate advancements in structural biology."
"FEI’s products also create new opportunities for us to serve customers in materials science markets that increasingly rely on nanotechnologies," he adds.
The company now expects to realise total synergies of approximately $80 million by year three following the close, consisting of approximately $55 million of cost synergies and approximately $25 million of adjusted operating income benefit from revenue-related synergies.
FEI stock will now cease trading and will no longer be listed on The NASDAQ Global Select Market.